Keenova Therapeutics plc Current Liabilities
Keenova Therapeutics plc had Current Liabilities of $660.60 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-11
- 2026-06-30: Liabilities, Current $660.60M.
- 2026-03-31: Liabilities, Current $638.30M.
- 2025-12-31: Liabilities, Current $672.10M.
- 2025-09-26: Liabilities, Current $1.07B.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $660.60M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $638.30M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $672.10M 10-Q · filed 2026-08-11 | |
| 2025-09-26 | $1.07B 10-Q · filed 2025-11-10 | |
| 2025-06-27 | $456.60M 10-Q · filed 2025-08-06 | |
| 2025-03-28 | $457.70M 10-Q · filed 2025-05-12 | |
| 2024-12-27 | $431.50M 10-K · filed 2026-04-15 | $431.40M 10-K · filed 2025-03-13 |
| 2024-09-27 | $553.70M 10-Q · filed 2024-11-05 | |
| 2024-06-28 | $482.00M 10-Q · filed 2024-08-06 | |
| 2024-03-29 | $476.00M 10-Q · filed 2024-05-09 | |
| 2023-12-29 | $501.20M 10-K · filed 2025-03-13 | |
| 2023-09-29 | $799.00M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $3.26B 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $693.70M 10-Q · filed 2023-05-09 | |
| 2022-12-30 | $743.80M 10-K · filed 2024-03-26 | |
| 2022-09-30 | $779.10M 10-Q · filed 2022-11-08 | |
| 2022-07-01 | $761.60M 10-Q · filed 2022-08-11 | |
| 2022-04-01 | $1.85B 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $1.94B 10-K · filed 2023-03-03 | |
| 2021-09-24 | $1.99B 10-Q · filed 2021-11-02 | |
| 2021-06-25 | $2.31B 10-Q · filed 2021-08-03 | |
| 2021-03-26 | $2.27B 10-Q · filed 2021-05-04 | |
| 2020-12-25 | $4.12B 10-K · filed 2022-03-15 | |
| 2020-09-25 | $6.50B 10-Q · filed 2020-11-03 | |
| 2020-06-26 | $1.32B 10-Q · filed 2020-08-04 | |
| 2020-03-27 | $1.28B 10-Q · filed 2020-05-06 | |
| 2019-12-27 | $1.43B 10-K · filed 2021-03-10 | |
| 2019-09-27 | $1.55B 10-Q · filed 2019-11-05 | |
| 2019-06-28 | $1.56B 10-Q · filed 2019-08-06 | |
| 2019-03-29 | $854.00M 10-Q · filed 2019-05-07 | |
| 2018-12-28 | $943.70M 10-K · filed 2020-02-26 | |
| 2018-09-28 | $922.60M 10-Q · filed 2018-11-06 | |
| 2018-06-29 | $884.50M 10-Q · filed 2018-08-07 | |
| 2018-03-30 | $1.10B 10-Q · filed 2018-05-08 | |
| 2017-12-29 | $1.05B 10-K · filed 2019-02-26 | |
| 2017-09-29 | $1.05B 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $1.36B 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $1.04B 10-Q · filed 2017-05-08 | |
| 2016-12-30 | $1.31B 10-K · filed 2018-02-27 | |
| 2016-09-30 | $1.23B 10-QT · filed 2017-02-07 | |
| 2016-06-24 | $969.50M 10-Q · filed 2016-08-02 | |
| 2016-03-25 | $892.10M 10-Q · filed 2016-05-03 | |
| 2015-12-25 | $888.30M 10-Q · filed 2016-02-02 | |
| 2015-09-25 | $929.40M 10-K · filed 2016-11-29 | |
| 2015-06-26 | $759.50M 10-Q · filed 2015-08-04 | |
| 2015-03-27 | $775.70M 10-Q · filed 2015-05-05 | |
| 2014-12-26 | $765.00M 10-Q · filed 2015-02-03 | |
| 2014-09-26 | $904.80M 10-K · filed 2015-11-24 | |
| 2014-06-27 | $638.60M 10-Q · filed 2014-08-07 | |
| 2014-03-28 | $625.80M 10-Q · filed 2014-05-08 | |
| 2013-12-27 | $554.00M 10-Q · filed 2014-02-07 | |
| 2013-09-27 | $600.20M 8-K · filed 2015-04-03 | |
| 2013-06-28 | $481.80M 10-Q · filed 2013-08-12 | |
| 2012-09-28 | $420.10M 10-K · filed 2013-12-13 | $395.80M 10-Q · filed 2013-08-12 |